We are live on ! Find out more
KFC

Klingenstein Fields & Co Portfolio holdings

AUM $2.54B
1-Year Est. Return 22.19%
This Fund
S&P 500
This Quarter Est. Return
+3%
1 Year Est. Return
+22.19%
3 Year Est. Return
+76.82%
5 Year Est. Return
+87.33%
10 Year Est. Return
+300.59%
AUM
$2.48B
AUM Growth
-$34.4M
Cap. Flow
-$68.7M
Cap. Flow %
-2.77%
Top 10 Hldgs %
37.3%
Holding
187
New
3
Increased
37
Reduced
75
Closed
7

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$5.23M
2
LLY icon
Eli Lilly
LLY
+$431K
3
ABT icon
Abbott
ABT
+$312K
4
EXEL icon
Exelixis
EXEL
+$227K
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$226K

Top Sells

Rank Stock Value
1
SCHF icon
Schwab International Equity ETF
SCHF
+$15.5M
2
SCHE icon
Schwab Emerging Markets Equity ETF
SCHE
+$14M
3
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$11.5M
4
AVGO icon
Broadcom
AVGO
+$8.48M
5
SCHA icon
Schwab U.S Small- Cap ETF
SCHA
+$3.08M

Sector Composition

Rank Sector Weight
1 Technology 26.97%
2 Financials 13.87%
3 Healthcare 11.95%
4 Communication Services 10.39%
5 Industrials 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OC icon
101
Owens Corning
OC
$11.6B
$852K 0.03%
5,000
– –
GILD icon
102
Gilead Sciences
GILD
$169B
$837K 0.03%
9,064
-1,500
-14% -$135K
WTM icon
103
White Mountains Insurance
WTM
$5.48B
$761K 0.03%
391
– –
GLW icon
104
Corning
GLW
$136B
$758K 0.03%
15,946
– –
ITOT icon
105
iShares Core S&P Total US Stock Market ETF
ITOT
$93.7B
$744K 0.03%
5,783
– –
EFA icon
106
iShares MSCI EAFE ETF
EFA
$76.5B
$693K 0.03%
9,165
– –
IWF icon
107
iShares Russell 1000 Growth ETF
IWF
$123B
$688K 0.03%
6,848
+1,820
+36% +$179K
NVS icon
108
Novartis
NVS
$293B
$661K 0.03%
6,797
– –
TSLA icon
109
Tesla
TSLA
$1.43T
$645K 0.03%
1,597
+20
+1% +$6.43K
BEPC icon
110
Brookfield Renewable
BEPC
$6.22B
$643K 0.03%
23,262
-191
-0.8% -$5.87K
IP icon
111
International Paper
IP
$20.1B
$639K 0.03%
11,865
– –
GLD icon
112
SPDR Gold Trust
GLD
$130B
$627K 0.03%
2,591
– –
CRC icon
113
California Resources
CRC
$4.63B
$609K 0.02%
11,737
– –
DGX icon
114
Quest Diagnostics
DGX
$23.2B
$603K 0.02%
4,000
– –
CSX icon
115
CSX Corp
CSX
$94.6B
$598K 0.02%
18,517
– –
ICE icon
116
Intercontinental Exchange
ICE
$80.2B
$549K 0.02%
3,684
– –
UITB icon
117
Victory Portfolios II VictoryShares Core Intermediate Bond ETF
UITB
$2.66B
$531K 0.02%
11,545
+366
+3% +$17.1K
UNH icon
118
UnitedHealth
UNH
$387B
$469K 0.02%
928
+3
+0.3% +$1.71K
BMY icon
119
Bristol-Myers Squibb
BMY
$124B
$456K 0.02%
8,063
-519
-6% -$29K
UBS icon
120
UBS Group
UBS
$173B
$453K 0.02%
14,930
– –
EUSA icon
121
iShares MSCI USA Equal Weighted ETF
EUSA
$1.8B
$452K 0.02%
4,737
– –
SPXE icon
122
ProShares S&P 500 ex-Energy ETF
SPXE
$83.3M
$447K 0.02%
7,070
– –
LIN icon
123
Linde
LIN
$241B
$432K 0.02%
1,031
+2
+0.2% +$911
LH icon
124
Labcorp
LH
$23.1B
$423K 0.02%
1,846
-84
-4% -$19.3K
BIIB icon
125
Biogen
BIIB
$30.8B
$418K 0.02%
2,731
-225
-8% -$38K
3 4
5
6 7

Similar funds

OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
LIMS
Lasalle Investment Management Securities Baltimore, Maryland $2.53B AUM 2.06% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
DJSG
D.J. St. Germain Springfield, Massachusetts $2.53B AUM 17.43% 1-Year Est. Return
SAM
Securian Asset Management St Paul, Minnesota $2.53B AUM 25.83% 1-Year Est. Return
JHP
James Hambro & Partners London, United Kingdom $2.55B AUM 17.58% 1-Year Est. Return
YDMI
Y.D. More Investments Ramat Gan, Israel $2.55B AUM 104.35% 1-Year Est. Return
ECP
Electron Capital Partners New York $2.55B AUM 87.77% 1-Year Est. Return

Klingenstein Fields & Co's Q4 2024 Portfolio in Review

As of Q4 2024, Klingenstein Fields & Co held 187 positions worth $2.48B, down 1.4% from $2.52B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Klingenstein Fields & Co's Q4 2024 filing shows 3 new, 37 increased, 75 reduced and 7 closed positions. Its largest new stake was Exelixis: 7,000 shares worth $233K. The largest sale was Schwab International Equity ETF, an estimated $15.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Klingenstein Fields & Co's largest Q4 2024 buy was Exelixis: 7,000 shares worth $233K.
  • Klingenstein Fields & Co added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $5.23M increase.
  • Klingenstein Fields & Co's biggest Q4 2024 reduction was Schwab International Equity ETF, cutting an estimated $15.5M.
  • Klingenstein Fields & Co fully exited First Trust Long/Short Equity ETF in Q4 2024, selling an estimated $2.04M.
  • Klingenstein Fields & Co's ten largest holdings make up 37% of its $2.48B portfolio in Q4 2024.
  • Klingenstein Fields & Co opened 3 new positions and closed 7 in Q4 2024.
  • Klingenstein Fields & Co's portfolio value fell 1.4% quarter-over-quarter to $2.48B.

Based on Klingenstein Fields & Co's 13F filing for Q4 2024, filed 30 Jan 2025.